This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
HIV Infections
and you are
between 18 and 50
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

This trial will study a prime-boost vaccine approach designed mainly to induce cell-mediated immune (CTL) responses.

Provided treatments

  • Biological: ADVAX
  • Biological: TBC-M4
  • Other: Placebo
Tris trial is registered with FDA with number: NCT00902824. The sponsor of the trial is International AIDS Vaccine Initiative and it is looking for 32 volunteers for the current phase.
Official trial title:
Phase I Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of TBC-M4 (MVA Based HIV Vaccine) Alone or in a Prime-Boost Regimen With ADVAX, DNA HIV Vaccine